United-Guardian (UG) Stock Price, News & Analysis

Company Overview

United-Guardian, Inc., headquartered in Hauppauge, New York, develops and supplies specialty ingredients and finished products for the personal care, cosmetic and esthetic markets. Its Specialty Ingredients segment offers antimicrobial preservatives, conditioning polymers, emulsifiers, UV filters and other functional actives that are incorporated into lotions, creams, shampoos and professional esthetic formulations.

The company’s Finished Products segment markets a range of skin and hair care items under the Guardian brand, providing private-label and contract manufacturing services to spas, salons and dermatology clinics. United-Guardian leverages its in-house research and development laboratories and regulatory expertise to support product formulation, testing and compliance with industry standards.

United-Guardian maintains manufacturing operations at its New York facility and distributes its products through a network of domestic and international partners. The company emphasizes quality control and innovation, collaborating with formulators and beauty professionals to address emerging trends in skin health, anti-aging and sun protection.

Key Stats

• Today's Range: $7.85 to $7.95
• 50-Day Range: $7.80 to $9.58
• 52-Week Range: $7.73 to $16.25
• Volume: 4,407 shs
• Average Volume: 7,620 shs
• Market Capitalization: $36.51 million
• P/E Ratio: 14.21
• Dividend Yield: 6.29%
• Price Target: N/A
• Consensus Rating: N/A

United-Guardian Stock Analysis - MarketRank™

United-Guardian scored higher than 48% of companies evaluated by MarketBeat, and ranked 653rd out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for United-Guardian.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of United-Guardian is 14.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.50.

Price to Earnings Ratio vs. Sector

The P/E ratio of United-Guardian is 14.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.23.

Price to Book Value per Share Ratio

United-Guardian has a P/B Ratio of 3.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.35% of the float of United-Guardian has been sold short.

Short Interest Ratio / Days to Cover

United-Guardian has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in United-Guardian has recently increased by 3.03%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

United-Guardian is a leading dividend payer. It pays a dividend yield of 6.41%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

United-Guardian has only been increasing its dividend for 1 years.

Dividend Coverage

The dividend payout ratio of United-Guardian is 89.29%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.35% of the float of United-Guardian has been sold short.

Short Interest Ratio / Days to Cover

United-Guardian has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in United-Guardian has recently increased by 3.03%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 4.1 / 5
• News Sentiment: 1.44

News Sentiment

United-Guardian has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for United-Guardian this week, compared to 0 articles on an average week.

Search Interest

1 people have searched for UG on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added United-Guardian to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, United-Guardian insiders have not sold or bought any company stock.

Percentage Held by Insiders

29.00% of the stock of United-Guardian is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 23.16% of the stock of United-Guardian is held by institutions.

UG Stock Analysis - Frequently Asked Questions

How have UG shares performed this year?

United-Guardian's stock was trading at $9.56 at the start of the year. Since then, UG stock has decreased by 15.2% and is now trading at $8.11.

How were United-Guardian's earnings last quarter?

United-Guardian, Inc. (NASDAQ:UG) released its quarterly earnings results on Friday, August, 8th. The company reported $0.14 earnings per share (EPS) for the quarter. The company earned $2.84 million during the quarter. United-Guardian had a net margin of 23.56% and a trailing twelve-month return on equity of 22.45%.

Who are United-Guardian's major shareholders?

Top institutional shareholders of United-Guardian include Gamco Investors INC. ET AL (3.47%).
View institutional ownership trends.

How do I buy shares of United-Guardian?

Shares of UG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of United-Guardian own?

Based on aggregate information from My MarketBeat watchlists, some other companies that United-Guardian investors own include Comtech Telecommunications (CMTL), Plug Power (PLUG), Alamos Gold (AGI), Workhorse Group (WKHS), Fortress Biotech (FBIO), FuelCell Energy (FCEL) and KALA BIO (KALA).

Company Calendar

• Record date for 8/1 Dividend: 7/25/2025
• Ex-Dividend for 8/1 Dividend: 7/25/2025
• Dividend Payable: 8/01/2025
• Last Earnings: 8/08/2025
• Today: 9/15/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Consumer Goods
• Current Symbol: NASDAQ:UG
• CIK: 101295
• Web: www.u-g.com
• Phone: (631) 273-0900
• Fax: 631-273-0858
• Employees: 20
• Year Founded: 1942

Profitability

• EPS (Trailing Twelve Months): $0.56
• Trailing P/E Ratio: 13.93
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.25 million
• Net Margins: 23.56%
• Pretax Margin: 29.81%
• Return on Equity: 22.45%
• Return on Assets: 19.22%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.73
• Quick Ratio: 5.90

Sales & Book Value

• Annual Sales: $12.18 million
• Price / Sales: 2.94
• Cash Flow: $0.73 per share
• Price / Cash Flow: 10.71
• Book Value: $2.59 per share
• Price / Book: 3.01

Miscellaneous

• Outstanding Shares: 4,590,000
• Free Float: 3,262,000
• Market Cap: $35.80 million
• Optionable: Not Optionable
• Beta: 0.96